Detalles de la búsqueda
1.
Implementation of a Molecular Tumor Board: The Impact on Treatment Decisions for 35 Patients Evaluated at Dartmouth-Hitchcock Medical Center.
Oncologist
; 20(9): 1011-8, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26205736
2.
Biomarker-Driven Personalized Immunoprevention: Toward More Efficient Clinical Trials?
Cancer Prev Res (Phila)
; : OF1-OF2, 2024 Jun 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38884213
3.
Pragmaticism in Cancer Clinical Trials.
Am Soc Clin Oncol Educ Book
; 44(3): e100040, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38771997
4.
Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing.
Nat Med
; 12(7): 852-5, 2006 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-16799556
5.
Major hurdles to the use of tyrosine kinase inhibitors in clinical prevention/interception studies: Do preclinical studies with EGFR inhibitors suggest approaches to overcome some of the limitations.
Front Cell Dev Biol
; 11: 1170444, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37169023
6.
Role of Neoadjuvant Immune Checkpoint Inhibitors in Resectable Non-Small Cell Lung Cancer.
Pharmaceuticals (Basel)
; 16(2)2023 Feb 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37259381
7.
Primary Prevention and Interception Studies in RAS-Mutated Tumor Models Employing Small Molecules or Vaccines.
Cancer Prev Res (Phila)
; 16(10): 549-560, 2023 10 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37468135
8.
Phase II Study of Docetaxel and Trametinib in Patients with KRAS Mutation Positive Recurrent Non-Small Cell Lung Cancer (NSCLC; SWOG S1507, NCT-02642042).
Clin Cancer Res
; 29(18): 3641-3649, 2023 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37233987
9.
Representativeness of Patients Enrolled in the Lung Cancer Master Protocol (Lung-MAP).
JCO Precis Oncol
; 7: e2300218, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37677122
10.
A phase I trial and in vitro studies combining ABT-751 with carboplatin in previously treated non-small cell lung cancer patients.
Chemotherapy
; 58(4): 321-9, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23147218
11.
Phase II Randomized Study of Ramucirumab and Pembrolizumab Versus Standard of Care in Advanced Non-Small-Cell Lung Cancer Previously Treated With Immunotherapy-Lung-MAP S1800A.
J Clin Oncol
; 40(21): 2295-2306, 2022 07 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35658002
12.
Prioritizing Measures That Matter Within a Person-Centered Oncology Learning Health System.
JNCI Cancer Spectr
; 6(3)2022 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35736219
13.
Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor response in metastatic renal cell carcinoma.
J Immunother Cancer
; 10(10)2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36252996
14.
A Phase II Trial of Prexasertib (LY2606368) in Patients With Extensive-Stage Small-Cell Lung Cancer.
Clin Lung Cancer
; 22(6): 531-540, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34034991
15.
Effects of Trilaciclib on Chemotherapy-Induced Myelosuppression and Patient-Reported Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer: Pooled Results from Three Phase II Randomized, Double-Blind, Placebo-Controlled Studies.
Clin Lung Cancer
; 22(5): 449-460, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33895103
16.
Alliance Foundation Trial 09: A Randomized, Multicenter, Phase 2 Trial Evaluating Two Sequences of Pembrolizumab and Standard Platinum-Based Chemotherapy in Patients With Metastatic NSCLC.
JTO Clin Res Rep
; 2(8): 100208, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34590049
17.
Uncovering growth-suppressive MicroRNAs in lung cancer.
Clin Cancer Res
; 15(4): 1177-83, 2009 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19228723
18.
A dose escalation trial of biweekly docetaxel and gemcitabine with filgrastim or pegfilgrastim for the treatment of patients with advanced solid tumors.
Chemotherapy
; 56(2): 135-41, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20407240
19.
CDK4/6 inhibition enhances antitumor efficacy of chemotherapy and immune checkpoint inhibitor combinations in preclinical models and enhances T-cell activation in patients with SCLC receiving chemotherapy.
J Immunother Cancer
; 8(2)2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33004541
20.
Rapid EGFR mutation testing in lung cancer tissue samples using a fully automated system and single-use cartridge.
Pract Lab Med
; 20: e00156, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32181314